Andeelyn Wardell, NP
Nurse Practitioner · Helena, MTNPI 1124642350
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Insulet Corporation at 38.4% of the total. 2025 is the largest year on record at $298, more than ten times the $13 reported in 2021.
Across 21 payments — averaging $31.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insulet Corporation$251
- Abbott$152
- Lilly USA, LLC$113
- Tandem Diabetes Care, Inc.$39
- Medtronic$32
- Novo Nordisk$29
- plus $37 from 2 others
What the payments were for
- Food & beverage$64198%
- Education$122%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insulet Corporation | 7 | $251 |
| Abbott | 2 | $152 |
| Lilly USA, LLC | 4 | $113 |
| Tandem Diabetes Care, Inc. | 2 | $39 |
| Medtronic | 2 | $32 |
| Novo Nordisk | 2 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FreeStyle Libre$116
- Omnipod$114
How this compares
$653 in reported general payments places this provider in the 85th percentile of 357 nurse practitioner providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 196 | $232,321 |
| TrulicityDulaglutide | 95 | $133,780 |
| Tresiba Flextouch U-200Insulin Degludec | 62 | $118,555 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 75 | $118,064 |
| JanuviaSitagliptin Phosphate | 119 | $100,646 |
| MounjaroTirzepatide | 70 | $99,672 |
| JardianceEmpagliflozin | 49 | $68,756 |
| Tresiba Flextouch U-100Insulin Degludec | 55 | $45,692 |
| Novolog FlexpenInsulin Aspart | 130 | $43,497 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 222 | $37,424 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 47 | $28,823 |
| FarxigaDapagliflozin Propanediol | 17 | $27,813 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 23 | $23,815 |
| Victoza 3-PakLiraglutide | 15 | $21,033 |
| Humalog Kwikpen U-100Insulin Lispro | 74 | $20,200 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog | $29 | $247,668255 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog, Insulin Lispro | $113 | $245,990238 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 357 nurse practitioner providers in Montana.
Other nurse practitioner in Helena
- Brittany CarnahanHelena$3K
- Samantha SmithHelena$2K
- Biljana MoratelliHelena$2K
- Caitlyn PateraHelena$1K
- Jenna ReitzHelena$458
- Sarah BergMissoula$381K
- Arlon BennettFlorence$268K
- Sydney HansonButte$11K
- Jennifer TerrellBillings$7K
- Amanda Abrams-BuerkleyBillings$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.